It has been another busy year for M&A in health tech and life sciences, from Allscripts acquisition of specialty drug platform ZappRx, UnitedHealth Group’s purchase of PatientsLikeMe, JP Morgan’s acquisition of medical billing business InstaMed, Bristol-Myers Squibb’s deal to buy Celgene and Google’s acquisition of Fitbit.
The interest in tools to support social determinants of health to improve patient access to healthier dietary options and transport to their appointments has increased as payers and providers see them as a way to help people manage chronic conditions and reduce the need for emergency hospitalization.
Where will strategic investors prioritize investments in 2020? Which healthcare and life science startups will generate buzz next year? What needs to happen for artificial intelligence in healthcare and life sciences to gain wider adoption? What are some of the collaborations that will help advance population health?
As you mull over those questions, we would encourage you to include these MedCity events in your planning as you review where to allocate your sponsorship and advertising budget in 2020. They also offer fantastic opportunities to take part in conversations around vital topics in healthcare, hear pitches from exciting healthcare startups and, of course, network.
When? April 21-22
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Where? Ritz Carlton, Chicago
The agenda for INVEST, put on in collaboration with Mid-America Healthcare Investors Network, is filled with hot topics in healthcare innovation from digital therapeutics, a debate on the merits of AI in healthcare, games in healthcare and more. Check out the preliminary agenda here. For more information about sponsorship opportunities, click here.
When? May 19
Where? New Orleans
The preliminary agenda for this conference with the New Orleans Business Alliance spotlights a variety of issues that touch on social determinants of health and population health. It will also provide a platform for startups that have developed tools to address chronic disease to talk about how they are taking on this challenge. For more information on sponsorship opportunities for this event, click here.
INVEST Precision Medicine (formerly CONVERGE)
When? June 25, 2020
Where? University City Science Center, Philadelphia, PA
We’ve changed the name and broadened the discussion topics for this conference beyond oncology to precision medicine. The preliminary agenda for this conference explores the intersection of health IT and biopharma from the use of digital health tools to identify drug development targets to innovation in clinical trial design. It will also explore advancements in gene therapy and address the reimbursement and manufacturing challenges that accompany them. To learn about sponsorship opportunities, click here.
When? September 22, 2020
Where? Minneapolis
This conference, in association with Medical Alley, brings together active investors with corporate business development executives to facilitate investment opportunities with the most innovative companies from the digital health sector. Check back for a preliminary agenda. For information on sponsorship opportunities, click here.
Periodically check each of these event pages for updates and sign up for MedCity’s newsletter so you don’t miss ticket discounts.
Photo: Rawpixel, Getty Images
